Alkylamines cause V¿9Vd2 T-cell activation by inhibiting the mevalonate pathway

Keith Thompson, J. Rojas-Navea, Michael John Rogers

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Three general classes of small, nonpeptide "antigens" activate V¿9Vd2 T cells: pyrophosphomonoesters, such as isopentenyl diphosphate (IPP), nitrogen-containing bisphosphonates (N-BPs), and alkylamines. However, we have shown recently that N-BPs indirectly activate V¿9Vd2 T cells as a consequence of inhibition of farnesyl diphosphate synthase (a key enzyme of the mevalonate pathway) and the intracellular accumulation of IPP. We now show that alkylamines activate V¿9Vd2 T cells by the same mechanism. Alkylamines were found to be weak inhibitors of farnesyl diphosphate synthase and caused accumulation of unprenylated Rap1A in peripheral blood mononuclear cells and macrophages, indicative of inhibition of the mevalonate pathway. Furthermore, as with N-BPs, the stimulatory effect of the alkylamines on V¿9Vd2 T cells was abrogated by simultaneous treatment with mevastatin. These findings suggest that only pyrophosphomonoesters such as IPP are true V¿9Vd2 T-cell agonists, whereas alkylamines and N-BPs indirectly activate V¿9Vd2 T cells through a common mechanism involving the accumulation of IPP.

Original languageEnglish
Pages (from-to)651-654
Number of pages3
JournalBlood
Volume107
Issue number2
DOIs
Publication statusPublished - Jan 2006

Keywords

  • nitrogen-containing bisphosphonates
  • acute-phase response
  • farnesyl diphosphate synthase
  • in-vitro
  • nonpeptide antigens
  • bone-resorption
  • gamma
  • pyrophosphate
  • geranylgeraniol
  • vivo

Cite this

Alkylamines cause V¿9Vd2 T-cell activation by inhibiting the mevalonate pathway. / Thompson, Keith; Rojas-Navea, J.; Rogers, Michael John.

In: Blood, Vol. 107, No. 2, 01.2006, p. 651-654.

Research output: Contribution to journalArticle

Thompson, Keith ; Rojas-Navea, J. ; Rogers, Michael John. / Alkylamines cause V¿9Vd2 T-cell activation by inhibiting the mevalonate pathway. In: Blood. 2006 ; Vol. 107, No. 2. pp. 651-654.
@article{1a85cd7c867e47f081a189debbe99567,
title = "Alkylamines cause V¿9Vd2 T-cell activation by inhibiting the mevalonate pathway",
abstract = "Three general classes of small, nonpeptide {"}antigens{"} activate V¿9Vd2 T cells: pyrophosphomonoesters, such as isopentenyl diphosphate (IPP), nitrogen-containing bisphosphonates (N-BPs), and alkylamines. However, we have shown recently that N-BPs indirectly activate V¿9Vd2 T cells as a consequence of inhibition of farnesyl diphosphate synthase (a key enzyme of the mevalonate pathway) and the intracellular accumulation of IPP. We now show that alkylamines activate V¿9Vd2 T cells by the same mechanism. Alkylamines were found to be weak inhibitors of farnesyl diphosphate synthase and caused accumulation of unprenylated Rap1A in peripheral blood mononuclear cells and macrophages, indicative of inhibition of the mevalonate pathway. Furthermore, as with N-BPs, the stimulatory effect of the alkylamines on V¿9Vd2 T cells was abrogated by simultaneous treatment with mevastatin. These findings suggest that only pyrophosphomonoesters such as IPP are true V¿9Vd2 T-cell agonists, whereas alkylamines and N-BPs indirectly activate V¿9Vd2 T cells through a common mechanism involving the accumulation of IPP.",
keywords = "nitrogen-containing bisphosphonates, acute-phase response, farnesyl diphosphate synthase, in-vitro, nonpeptide antigens, bone-resorption, gamma, pyrophosphate, geranylgeraniol, vivo",
author = "Keith Thompson and J. Rojas-Navea and Rogers, {Michael John}",
year = "2006",
month = "1",
doi = "10.1182/BLOOD-2005-03-1025",
language = "English",
volume = "107",
pages = "651--654",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Alkylamines cause V¿9Vd2 T-cell activation by inhibiting the mevalonate pathway

AU - Thompson, Keith

AU - Rojas-Navea, J.

AU - Rogers, Michael John

PY - 2006/1

Y1 - 2006/1

N2 - Three general classes of small, nonpeptide "antigens" activate V¿9Vd2 T cells: pyrophosphomonoesters, such as isopentenyl diphosphate (IPP), nitrogen-containing bisphosphonates (N-BPs), and alkylamines. However, we have shown recently that N-BPs indirectly activate V¿9Vd2 T cells as a consequence of inhibition of farnesyl diphosphate synthase (a key enzyme of the mevalonate pathway) and the intracellular accumulation of IPP. We now show that alkylamines activate V¿9Vd2 T cells by the same mechanism. Alkylamines were found to be weak inhibitors of farnesyl diphosphate synthase and caused accumulation of unprenylated Rap1A in peripheral blood mononuclear cells and macrophages, indicative of inhibition of the mevalonate pathway. Furthermore, as with N-BPs, the stimulatory effect of the alkylamines on V¿9Vd2 T cells was abrogated by simultaneous treatment with mevastatin. These findings suggest that only pyrophosphomonoesters such as IPP are true V¿9Vd2 T-cell agonists, whereas alkylamines and N-BPs indirectly activate V¿9Vd2 T cells through a common mechanism involving the accumulation of IPP.

AB - Three general classes of small, nonpeptide "antigens" activate V¿9Vd2 T cells: pyrophosphomonoesters, such as isopentenyl diphosphate (IPP), nitrogen-containing bisphosphonates (N-BPs), and alkylamines. However, we have shown recently that N-BPs indirectly activate V¿9Vd2 T cells as a consequence of inhibition of farnesyl diphosphate synthase (a key enzyme of the mevalonate pathway) and the intracellular accumulation of IPP. We now show that alkylamines activate V¿9Vd2 T cells by the same mechanism. Alkylamines were found to be weak inhibitors of farnesyl diphosphate synthase and caused accumulation of unprenylated Rap1A in peripheral blood mononuclear cells and macrophages, indicative of inhibition of the mevalonate pathway. Furthermore, as with N-BPs, the stimulatory effect of the alkylamines on V¿9Vd2 T cells was abrogated by simultaneous treatment with mevastatin. These findings suggest that only pyrophosphomonoesters such as IPP are true V¿9Vd2 T-cell agonists, whereas alkylamines and N-BPs indirectly activate V¿9Vd2 T cells through a common mechanism involving the accumulation of IPP.

KW - nitrogen-containing bisphosphonates

KW - acute-phase response

KW - farnesyl diphosphate synthase

KW - in-vitro

KW - nonpeptide antigens

KW - bone-resorption

KW - gamma

KW - pyrophosphate

KW - geranylgeraniol

KW - vivo

U2 - 10.1182/BLOOD-2005-03-1025

DO - 10.1182/BLOOD-2005-03-1025

M3 - Article

VL - 107

SP - 651

EP - 654

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -